Login to Your Account

Financings Roundup

Ironwood Raises $79M for Linaclotide Launch Prep

By Trista Morrison
Staff Writer

Monday, February 13, 2012
With lead drug linaclotide under FDA review for irritable bowel syndrome and chronic constipation, Ironwood Pharmaceuticals Inc. added $79.2 million to its coffers.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription